Dario Amodei says AI will cure cancer and Alzheimer's in a decade. Doctors aren't buying it.
Some in the medical community aren't so certain that AI will cure cancer and Alzheimer's in the next decade, as Anthropic CEO Dario Amodei predicted.
Headlines compared
Common ground: most headlines mention “Anthropic’s Dario Amodei”.
Different angles:
- Business Insider “decade Doctors aren't buying”
- The New York Times “Angered OpenAI and Other”
- Financial Times “super fussed about market turmoil”
- Bloomberg “IPO Makes”
One of the 4 headlines quotes someone directly.
How 4 newspapers cover this story
Dario Amodei says AI will cure cancer and Alzheimer's in a decade. Doctors aren't buying it.
Some in the medical community aren't so certain that AI will cure cancer and Alzheimer's in the next decade, as Anthropic CEO Dario Amodei predicted.
· The 4 types of people Dario Amodei said he won’t hire — and what Anthropic looks for instead
Why Anthropic’s Dario Amodei Has Angered OpenAI and Other A.I. Peers
Dario Amodei, the company’s chief executive, publicly frets about the dangers of artificial intelligence and has made enemies of his peers along the way.
Anthropic’s Dario Amodei ‘not super fussed’ about market turmoil
AI lab’s chief executive brushes off tech stock turbulence less than a week before its planned $1.5tn IPO
Anthropic’s IPO Makes Dario Amodei the New Face of the AI Boom
The startup is set for the biggest IPO of all time, putting AI investors’ hopes and dreams — and fears — onto a frontier model maker.
Coverage details
4 outlets from 2 countries are covering this story: Business Insider, The New York Times, Financial Times and Bloomberg. Business Insider published it first, on November 11, 2026; the last outlet to join was Bloomberg, 4 days later.
Key names in the coverage: Dario Amodei, Anthropic and IPO.
By country: United States (3), United Kingdom (1). In total 5 articles have been published, because some outlets updated the story several times.


